Skip to main content
HWAIL PHARM. CO., LTD logo

HWAIL PHARM. CO., LTD — Investor Relations & Filings

Ticker · 061250 ISIN · KR7061250007 KO Manufacturing
Open in API
Filings indexed 272 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 061250

About HWAIL PHARM. CO., LTD

http://www.hwail.com/

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Recent filings

Filing Released Lang Actions
주권매매거래정지해제 (액면병합 주권 변경상장)
Regulatory Filings
2026-04-30 Korean
소속부변경
Regulatory Filings
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory form titled “임원ㆍ주요주주 특정증권등 소유상황보고서” which literally reports the ownership and changes in specific securities by a director or major shareholder. It lists the director’s name, share counts before and after, percentages, change reasons, and transaction details. This matches the insider transaction/Director’s Dealing category. Therefore, it should be classified as DIRS.
2026-04-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory filing in Korean titled "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on ownership status of certain securities by officers and major shareholders). It details insider share ownership changes, shares held, percentages, acquisition/disposition dates, and is addressed to the Securities and Futures Commission and Korea Exchange. This matches the definition of a Director's Dealing report (personal share transactions by company directors/executives and major shareholders).
2026-04-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a statutory ‘주식등의 대량보유상황보고서’ (Large Shareholding Status Report) filed under the Capital Markets Act Article 147, detailing changes in major shareholdings, thresholds, percentages, and related disclosures. This matches our “Major Shareholding Notification” category (MRQ).
2026-04-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a statutory “임원ㆍ주요주주 특정증권등 소유상황보고서” disclosing an executive’s personal shareholdings and changes (insider trades). It contains detailed insider share ownership figures, acquisition/disposition dates, and executive identity. This corresponds to a Director’s Dealing report (insider transactions).
2026-04-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.